Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 31.10.2020 at 7:00 AM CET
Settings

Settings

Goto Application

1. MX2018014559 - COMPOSICION NUTRITIVA QUE COMPRENDE UN PROBIOTICO PARA PREVENIR Y/O TRATAR TRASTORNOS DE ANSIEDAD Y AFECCIONES RELACIONADAS EN UN MAMIFERO.

Office Mexico
Application Number 2018014559
Application Date 26.11.2018
Publication Number 2018014559
Publication Date 28.03.2019
Publication Kind A
IPC
A61K 35/744
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
CPC
A23L 33/135
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
135Bacteria or derivatives thereof, e.g. probiotics
A23L 33/40
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
A61K 35/744
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
A61K 35/745
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
745Bifidobacteria
A61K 35/747
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
747Lactobacilli, e.g. L. acidophilus or L. brevis
A61P 25/22
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
22Anxiolytics
Applicants NESTEC S.A.
Inventors Nora SCHNEIDER
Carine BLANCHARD
Ellen Siobhan MITCHELL
Chiara NEMBRINI
Priority Data 16177649.7 01.07.2016 EP
Title
(EN) COMPOSICION NUTRITIVA QUE COMPRENDE UN PROBIOTICO PARA PREVENIR Y/O TRATAR TRASTORNOS DE ANSIEDAD Y AFECCIONES RELACIONADAS EN UN MAMIFERO.
(ES) COMPOSICION NUTRITIVA QUE COMPRENDE UN PROBIOTICO PARA PREVENIR Y/O TRATAR TRASTORNOS DE ANSIEDAD Y AFECCIONES RELACIONADAS EN UN MAMIFERO.
Abstract
(EN)
The invention concerns a composition comprising probiotic selected from the group consisting of Lactococcus lactis and a combination of Bifidobacterium longum and Lactobacillus rhamnosus, preferably strain Lactococcus lactis or a combination of strains Lactobacillus rhamnosus LPR and Bifidobacterium longum BL 999, for use in preventing and/or treating anxiety disorders and related conditions like chronic stress, depression and mood regulation in a mammal. The composition is preferably a nutritional composition for humans, more specifically selected from the group consisting of pregnant women, lactating women and children, even more preferably by pregnant women, lactating women or infants. In a preferred embodiment, the nutritional composition is an infant formula.

(ES)
La invención se refiere a una composición que comprende probióticos seleccionados del grupo que consiste en Lactococcus lactis y una combinación de Bifidobacterium longum y Lactobacillus rhamnosus, preferentemente la cepa Lactococcus lactis o una combinación de cepas Lactobacillus rhamnosus LPR y Bifidobacterium longum BL 999, para usar en la prevención y/o tratamiento de trastornos de ansiedad y afecciones relacionadas como estrés crónico, depresión y regulación del estado de ánimo en un mamífero. La composición es preferentemente una composición nutritiva para seres humanos, más específicamente se selecciona del grupo que consiste en mujeres embarazadas, mujeres lactantes y niños, aún con mayor preferencia para mujeres embarazadas, mujeres lactantes o infantes. En una modalidad preferida, la composición nutritiva es una fórmula infantil.

Also published as
PH12018502300
SG11201809593Y